Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

The role of endoscopic ultrasound in pancreatic cancer screening.

Bhutani MS, Koduru P, Joshi V, Saxena P, Suzuki R, Irisawa A, Yamao K.

Endosc Ultrasound. 2016 Jan-Feb;5(1):8-16. doi: 10.4103/2303-9027.175876.

2.

A two-stage approach to genetic risk assessment in primary care.

Biswas S, Atienza P, Chipman J, Blackford AL, Arun B, Hughes K, Parmigiani G.

Breast Cancer Res Treat. 2016 Jan;155(2):375-83. doi: 10.1007/s10549-016-3686-2. Epub 2016 Jan 19.

PMID:
26786860
3.

Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients.

Mughetti M, Calculli L, Chiesa AM, Ciccarese F, Rrusho O, Pezzilli R.

BMC Gastroenterol. 2016 Jan 15;16(1):6. doi: 10.1186/s12876-016-0421-8.

4.

Development and Validation of a Prediction Model to Estimate Individual Risk of Pancreatic Cancer.

Yu A, Woo SM, Joo J, Yang HR, Lee WJ, Park SJ, Nam BH.

PLoS One. 2016 Jan 11;11(1):e0146473. doi: 10.1371/journal.pone.0146473. eCollection 2016.

5.

Early detection of pancreatic cancer.

Kim VM, Ahuja N.

Chin J Cancer Res. 2015 Aug;27(4):321-31. doi: 10.3978/j.issn.1000-9604.2015.07.03. Review.

6.

Screening for pancreatic cancer in familial high-risk individuals: A systematic review.

Lu C, Xu CF, Wan XY, Zhu HT, Yu CH, Li YM.

World J Gastroenterol. 2015 Jul 28;21(28):8678-86. doi: 10.3748/wjg.v21.i28.8678. Review.

7.

Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec.

Smith AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, Amre R, Caglar D, Gao ZH, Haegert DG, Kanber Y, Michel RP, Omeroglu-Altinel G, Asselah J, Bouganim N, Kavan P, Arena G, Barkun J, Chaudhury P, Gallinger S, Foulkes WD, Omeroglu A, Metrakos P, Zogopoulos G.

Curr Oncol. 2015 Apr;22(2):113-21. doi: 10.3747/co.22.2300.

8.

Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.

Urayama S.

World J Gastroenterol. 2015 Feb 14;21(6):1707-17. doi: 10.3748/wjg.v21.i6.1707. Review.

9.

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology.

Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263. doi: 10.1038/ajg.2014.435. Epub 2015 Feb 3. Review.

10.

High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening.

Bruenderman EH, Martin RC 2nd.

J Surg Res. 2015 Mar;194(1):212-9. doi: 10.1016/j.jss.2014.06.046. Epub 2014 Oct 13. Review.

11.

Genetic predisposition to pancreatic cancer.

Ghiorzo P.

World J Gastroenterol. 2014 Aug 21;20(31):10778-89. doi: 10.3748/wjg.v20.i31.10778. Review.

12.

Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer.

Lami G, Biagini MR, Galli A.

World J Gastrointest Endosc. 2014 Jul 16;6(7):272-85. doi: 10.4253/wjge.v6.i7.272. Review.

13.

The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?

Lennon AM, Wolfgang CL, Canto MI, Klein AP, Herman JM, Goggins M, Fishman EK, Kamel I, Weiss MJ, Diaz LA, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH.

Cancer Res. 2014 Jul 1;74(13):3381-9. doi: 10.1158/0008-5472.CAN-14-0734. Epub 2014 Jun 12. Review.

14.

Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma.

Reznik R, Hendifar AE, Tuli R.

Front Physiol. 2014 Mar 3;5:87. doi: 10.3389/fphys.2014.00087. eCollection 2014. Review.

15.

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.

Lu KH, Wood ME, Daniels M, Burke C, Ford J, Kauff ND, Kohlmann W, Lindor NM, Mulvey TM, Robinson L, Rubinstein WS, Stoffel EM, Snyder C, Syngal S, Merrill JK, Wollins DS, Hughes KS; American Society of Clinical Oncology.

J Clin Oncol. 2014 Mar 10;32(8):833-40. doi: 10.1200/JCO.2013.50.9257. Epub 2014 Feb 3. No abstract available.

16.

Familial pancreatic cancer: genetic advances.

Rustgi AK.

Genes Dev. 2014 Jan 1;28(1):1-7. doi: 10.1101/gad.228452.113. Review.

17.

Risk factors and therapeutic targets in pancreatic cancer.

Wörmann SM, Algül H.

Front Oncol. 2013 Nov 18;3:282. doi: 10.3389/fonc.2013.00282. Review.

18.

Familial pancreatic cancer.

Lynch HT, Lynch JF, Lanspa SJ.

Cancers (Basel). 2010 Nov 10;2(4):1861-83. doi: 10.3390/cancers2041861.

19.

An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.

Klein AP, Lindström S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Lacroix A, Li D, Mandelson MT, Olson SH, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Zheng W, Amundadottir L, Albanes D, Allen NE, Bamlet WR, Boutron-Ruault MC, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, Duell EJ, Elena J, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hassan M, Hutchinson A, Hunter DJ, Kooperberg C, Kurtz RC, Liu S, Overvad K, Palli D, Patel AV, Rabe KG, Shu XO, Slimani N, Tobias GS, Trichopoulos D, Van Den Eeden SK, Vineis P, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hoover RN, Hartge P, Kraft P.

PLoS One. 2013 Sep 13;8(9):e72311. doi: 10.1371/journal.pone.0072311. eCollection 2013.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk